These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 197427)

  • 21. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects.
    Pasternak GW
    Ann N Y Acad Sci; 1986; 467():130-9. PubMed ID: 3014970
    [No Abstract]   [Full Text] [Related]  

  • 23. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB
    Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons.
    van Vliet BJ; Mulder AH; Schoffelmeer AN
    Prog Clin Biol Res; 1990; 328():409-12. PubMed ID: 2154799
    [No Abstract]   [Full Text] [Related]  

  • 25. Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions.
    Voorn P; Roest G; Groenewegen HJ
    Brain Res; 1987 Jun; 412(2):391-6. PubMed ID: 2440523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for two subtypes of delta opioid receptors in rat brain.
    Negri L; Potenza RL; Corsi R; Melchiorri P
    Eur J Pharmacol; 1991 Apr; 196(3):335-6. PubMed ID: 1654257
    [No Abstract]   [Full Text] [Related]  

  • 27. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in prodynorphin peptide content following treatment with morphine or amphetamine: possible role in mechanisms of action of drug of abuse.
    Trujillo KA; Akil H
    NIDA Res Monogr; 1989; 95():550-1. PubMed ID: 2561855
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.
    Schotte A; Leysen JE
    J Chem Neuroanat; 1989; 2(5):253-7. PubMed ID: 2553068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum.
    Descarries L; Bosler O; Berthelet F; Des Rosiers MH
    Nature; 1980 Apr; 284(5757):620-2. PubMed ID: 7366732
    [No Abstract]   [Full Text] [Related]  

  • 33. Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system.
    Simantov R; Kuhar MJ; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2167-71. PubMed ID: 194249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bromocriptine on receptor binding of methionine-enkephalin.
    Ogawa N; Yamawaki Y; Kuroda H; Ofuji T
    Neurosci Lett; 1981 May; 23(2):215-8. PubMed ID: 6265839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat.
    Marchi M; Volpe G; Augliera A; Codignola A; Lunardi G; Raiteri M
    Neurochem Int; 1992 Mar; 20 Suppl():271S-274S. PubMed ID: 1365441
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced affinity of mu-opioid receptors in morphine-dependent mice.
    Abdelhamid EE; Takemori AE
    Prog Clin Biol Res; 1990; 328():523-6. PubMed ID: 2154814
    [No Abstract]   [Full Text] [Related]  

  • 39. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
    Clarke PB; Pert A
    Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.